The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression
Open accessAbstract
Glioblastoma is the most lethal primary brain tumor; however, the crosstalk between glioblastoma stem cells (GSCs) and their supportive niche is not well understood. Here, we interrogated reciprocal signaling between GSCs and their differentiated glioblastoma cell (DGC) progeny. We found that DGCs accelerated GSC tumor growth. DGCs preferentially expressed brain-derived neurotrophic factor (BDNF), whereas GSCs expressed the BDNF receptor NTRK2. Forced BDNF expression in DGCs augmented GSC tumor growth. To determine molecular mediators of BDNF-NTRK2 paracrine signaling, we leveraged transcriptional and epigenetic profiles of matched GSCs and DGCs, revealing preferential VGF expression by GSCs, which patient-derived tumor models confirmed. VGF serves a dual role in the glioblastoma hierarchy by promoting GSC survival and stemness in vitro and in vivo while also supporting DGC survival and inducing DGC secretion of BDNF. Collectively, these data demonstrate that differentiated glioblastoma cells cooperate with stem-like tumor cells through BDNF-NTRK2-VGF paracrine signaling to promote tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In line with these observations, it has been recently shown that BDNF produced by glioblastoma (GBM) differentiated cells acts on GBM stem cells, fostering their growth through paracrine signaling [258].”
From Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer (2020) · cites this paper as [258]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Self-citationFast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839
deepTools2: a next generation web server for deep-sequencing data analysis
Ramírez, F., Ryan, D. P., Grüning, B., Bhardwaj, V., Kilpert, F., Richter, A. S., Heyne, S., Dündar, F., & Manke, T. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw257 · Cited by 8,096
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 285
Chronic hypoxia remodels the tumor microenvironment to support glioma stem cell growth
Nicholson, J., Cirigliano, S. M., Singhania, R., Haywood, C., Dadras, M. S., Yoshimura, M., Vanderbilt, D. B., Liechty, B., & Fine, H. A. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01755-6 · Cited by 26
Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma
Valle‐García, D., de la Cruz, V. P., Flores, I., Salazar, A., Pineda, B., & Meza‐Sosa, K. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052464 · Cited by 26
Song, S., Ma, D., Xu, L., Wang, Q., Liu, L., Tong, X., & Yan, H. (2021) · iScience · doi:10.1016/j.isci.2021.103558 · Cited by 24
Superenhancers as master gene regulators and novel therapeutic targets in brain tumors
Zhuang, H.-H., Qu, Q., Teng, X.-Q., Dai, Y.-H., & Qu, J. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00934-0 · Cited by 24
McFaline‐Figueroa, J. L., Srivatsan, S. R., Hill, A. J., Gasperini, M. J., Jackson, D. L., Saunders, L. M., Domcke, S., Regalado, S. G., Lazarchuck, P., Alvarez, S., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2023.100487 · Cited by 25
Sengupta, S., Mondal, M., Prasasvi, K. R., Mukherjee, A., Magod, P., Urbach, S., Friedmann‐Morvinski, D., Marin, P., & Somasundaram, K. (2022) · eLife · doi:10.7554/elife.78972 · Cited by 22
Characterizing the heterogeneity in 5-aminolevulinic acid–induced fluorescence in glioblastoma
Bonnin, D. A. A., Havrda, M. C., Lee, M. C., Evans, L. T., Ran, C., Qian, D. C., Harrington, L. X., Valdes, P. A., Cheng, C., Amos, C. I., et al. (2019) · Journal of neurosurgery · doi:10.3171/2019.2.jns183128 · Cited by 22
Wang, X., Li, R., Zhu, Y., Wang, Z., Zhang, H., Cui, L., Duan, S., & Guo, Y. (2019) · Materials Chemistry Frontiers · doi:10.1039/c9qm00666d · Cited by 22
Self-citationOligodendrocyte Progenitor Cells in the Tumor Microenvironment
Hide, T., & Komohara, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-37184-5_8 · Cited by 23
Yu, Q., Wang, Y., Yi, G., Yang, W., Chen, K., Tan, X., Zhang, X., Xu, Z., Yang, Z., & Peng, Y. (2022) · Immunology · doi:10.1111/imm.13581 · Cited by 21
Al‐Holou, W. N., Wang, H., Ravikumar, V., Shankar, S., Oneka, M. D., Fehmi, Z., Verhaak, R. G. W., Kim, H., Pratt, D. W., Camelo-Piragua, S. I., et al. (2023) · Neoplasia · doi:10.1016/j.neo.2022.100872 · Cited by 20
Boosting Nanomedicine Efficacy with Hyperbaric Oxygen Therapy
Wang, X., Li, S., Liu, X., Wu, X. G., Ye, N., Yang, X., & Li, Z. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-58174-9_4 · Cited by 20
Self-citationPatient-derived tumor organoids mimic treatment-induced DNA damage response in glioblastoma
Majc, B., Habič, A., Malavolta, M., Vittori, M., Porčnik, A., Boŝnjak, R., Mlakar, J., Matjašič, A., Zupan, A., Vidmar, M. S., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110604 · Cited by 19
Mollazadeh, H., Mohtashami, E., Mousavi, S. H., Soukhtanloo, M., Vahedi, M. M., Hosseini, A., Afshari, A. R., & Sahebkar, A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200603132456 · Cited by 19
Boskovic, P., Wilke, N., Man, K.-H., Lichter, P., Francois, L., & Radlwimmer, B. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad190 · Cited by 18
Wu, Z., Jiao, M., Shu, C., Zhang, S., Wang, J., Pu, J., Zhu, J., Zeng, Y., Zhu, Y., & Liu, Z. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01639-1 · Cited by 18
Jeon, H.-M., Shin, Y. J., Lee, J., Chang, N., Woo, D., Lee, W. J., Nguyen, D., Kang, W., Cho, H. J., Yang, H., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.167049 · Cited by 18
Park, S., Avera, A. D., & Kim, Y. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28191 · Cited by 17
Cellular neighborhoods in cancer
Ma, L., Xiong, B., Liu, M., & Tan, K. (2026) · Nature Cancer · doi:10.1038/s43018-025-01107-w · Cited by 16
Wei, Y., Geng, S., Si, Y., Yang, Y., Chen, Q., Huang, S., Chen, X., Xu, W., Liu, Y., & Jiang, J. (2023) · Advanced Science · doi:10.1002/advs.202306715 · Cited by 16
SUV39H1 maintains cancer stem cell chromatin state and properties in glioblastoma
Li, C., Xie, Q., Ghosh, S., Cao, B., Du, Y., Giau, V. V., Huang, T. Y., Spruck, C., Carpenter, R. L., Wang, Y., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.186344 · Cited by 17
Wang, X., Xu, Z., Chen, X., Ren, X., Wei, J., Zhou, S., Yang, X., Zeng, S., Qian, L., Wu, G., et al. (2019) · PeerJ · doi:10.7717/peerj.7125 · Cited by 16
Self-citationXing, Y. L., Panovska, D., Park, J., Grossauer, S., Koeck, K., Bui, B., Nasajpour, E., Nirschl, J., Feng, Z.-P., Cheung, P., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102183 · Cited by 15
Prateeksha, P., Howlader, M. S. I., Hansda, S., Naidu, P., Das, M., Abo-Aziza, F. A. M., & Das, H. (2023) · Diseases & Research · doi:10.54457/dr.202302006 · Cited by 16
Investigational treatment strategies in glioblastoma: progress made and barriers to success
Nelson, T. A., & Dietrich, J. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2267982 · Cited by 15
Neural regulation of drug resistance in cancer treatment
Liu, D., Li, X., Chen, X., Sun, Y. H., Tang, A., Li, Z., Zheng, J., & Shi, M. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.10.001 · Cited by 15
GASC1 Promotes Stemness of Esophageal Squamous Cell Carcinoma via NOTCH1 Promoter Demethylation
Jia, R., Yang, L., Yuan, X., Kong, J., Liu, Y., Yin, W., Gao, S., & Zhang, Y. (2019) · Journal of Oncology · doi:10.1155/2019/1621054 · Cited by 15
Bai, L., Hao, Z., Wang, S., Zhou, J., Yao, S., Pei, N., Zhu, H., Zhang, K., Reis, R. L., Oliveira, J. M., et al. (2023) · International Journal of Bioprinting · doi:10.18063/ijb.715 · Cited by 15
Li, F., Yang, K., Gao, X., Zhang, M., Gu, D., Wu, X., Lu, C., Wu, Q., Dixit, D., Gimple, R. C., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk9524 · Cited by 14
Self-citationNizar, R., Cazacu, S., Xiang, C., Krasner, M., Barbiro‐Michaely, E., Gerber, D., Schwartz, J., Fried, I., Bar‐Asher, S. Y., Brodie, A., et al. (2023) · Cells · doi:10.3390/cells12151921 · Cited by 14
Heterogeneous Glioma Cell Invasion Under Interstitial Flow Depending on Their Differentiation Status
Namba, N., Chonan, Y., Nunokawa, T., Sampetrean, O., Saya, H., & Sudo, R. (2021) · Tissue Engineering Part A · doi:10.1089/ten.tea.2020.0280 · Cited by 13
Noorden, C. J. F. V., Breznik, B., Novak, M., van Dijck, A. J., Tanan, S., Vittori, M., Bogataj, U., Bakker, N., Khoury, J. D., Molenaar, R. J., et al. (2021) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554211054585 · Cited by 15
Rak, J. W., & Strządała, L. (2023) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-023-00671-2 · Cited by 13
Turnšek, T. L., Jiao, X., Novak, M., Jammula, S., Cicero, G., Ashton, A. W., Joyce, D. A., & Pestell, R. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094464 · Cited by 14
Hazra, R., Utama, R., Naik, P. K., Dobin, A., & Spector, D. L. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.10.004 · Cited by 12
Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma
Pinheiro, K. V., Thomaz, A., Souza, B. K., Metcalfe, V. A., Freire, N. H., Brunetto, A. T., de Farias, C. B., Jaeger, M. D. C., Bambini-Júnior, V., Smith, C. G., et al. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05739-2 · Cited by 11
Palanichamy, K., Jacob, J. R., Litzenberg, K. T., Ray‐Chaudhury, A., & Chakravarti, A. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.019 · Cited by 11
Spatial epigenomic niches underlie glioblastoma cell state plasticityPreprint
Kint, S., Younes, S. T., Bao, S., Long, G., Wouters, D., Stephenson, E. L., Lou, X., Zhong, M., Zhang, D., Su, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.09.653178 · Cited by 11
Self-citationMulti-omics analysis identifies glioblastoma dependency on H3K9me3 methyltransferase activity
Xie, Q., Du, Y., Ghosh, S., Rajendran, S., Cohen-Gadol, A. A., Baizabal, J.-M., Nephew, K. P., Han, L., & Shen, J. (2025) · NPJ Precision Oncology · doi:10.1038/s41698-025-00829-5 · Cited by 10
Unlocking Glioblastoma Vulnerabilities with CRISPR-Based Genetic Screening
Fang, Y., Li, X., & Tian, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115702 · Cited by 12
Ouyang, S., Shi, S., Ding, W., Yang, G., Su, Y., Mo, J., Peng, K., Zhang, Q., Liu, G., Xiao, W., et al. (2024) · Advanced Science · doi:10.1002/advs.202407967 · Cited by 10
Tumor Innervation: From Bystander to Emerging Therapeutic Target for Cancer
Ji, Z. Z., Chan, M. K., Tang, P. C., Ng, C. S. H., Li, C., Zhang, D., Nikolic‐Paterson, D. J., To, K., Jiang, X., & Tang, P. M.-K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189257 · Cited by 11
Chromium (VI)‐induced ALDH1A1/EGF axis promotes lung cancer progression
Ge, X. Q., Li, M., Song, G., Zhang, Z., Yin, J., Ge, Z., Shi, Z., Liu, L.-Z., Jiang, B., Qian, X., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1136 · Cited by 9
Steponaitis, G., Dragūnaitė, R., Stakaitis, R., Sharma, A., Tamašauskas, A., & Skiriutė, D. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01254-x · Cited by 12
Maturi, N. P., Tan, E., Xie, Y., Sundström, A., Bergström, T., Jiang, Y., & Uhrbom, L. (2019) · Glia · doi:10.1002/glia.23773 · Cited by 9
Servidei, T., Lucchetti, D., Navarra, P., Sgambato, A., Riccardi, R., & Ruggiero, A. (2021) · Cancers · doi:10.3390/cancers13236100 · Cited by 9
Novel CAR-T cells targeting TRKB for the treatment of solid cancer
Liang, D., Tang, J., Sun, B., He, S., Yang, D., Ma, H., Yun, Y., Zhu, Y., Wei, W., Chen, H., et al. (2024) · APOPTOSIS · doi:10.1007/s10495-024-01936-7 · Cited by 8
Geng, W., Zou, H. L., Wang, H., Dai, Y., Lu, G., Sun, Z., Lü, Y., Ding, X., & Yu, Y. (2021) · Nanoscale · doi:10.1039/d0nr08899d · Cited by 8
Gupta, R., Dittmeier, M., Wohlleben, G., Nickl, V., Bischler, T., Luzak, V., Wegat, V., Doll, D., Sodmann, A., Bady, E., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00809-0 · Cited by 7
Feng, Y., Wang, W., Zhang, Y., Feng, Y., Zhao, Y., Zhang, Z., & Wang, Y. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70290 · Cited by 7
Inoki, T., Tsuruta, A., Masakado, Y., Kai, Y., Yoshida, Y., Matsunaga, N., Ohdo, S., & Koyanagi, S. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108544 · Cited by 7
Endothelial cells-derived SEMA3G suppresses glioblastoma stem cells by inducing c-Myc degradation
Min, P., Feng, L.-L., Zhang, Y., Jiang, C., Zhang, H.-Z., Chen, Y., Fukunaga, K., Liu, F., Zhang, Y., Sasaki, T., et al. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01534-3 · Cited by 7
Stress granules restrain ferroptosis by sequestering ferritin
Ge, Z., Wang, Z., Zhao, E., Guo, Y., Zhang, L., Tian, F., Li, M., L, Y., Ding, F., He, L., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01953-5 · Cited by 7
Self-citationGao, X., Liu, Y., Hong, S., Yang, H., Guan, B., & Ma, X. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2205130 · Cited by 7
Lineage specification in glioblastoma is regulated by METTL7B
Constantinou, M., Nicholson, J., Zhang, X., Maniati, E., Lucchini, S., Rosser, G., Vinel, C., Wang, J., Lim, Y. M., Brandner, S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114309 · Cited by 7
Carvalho, R., Santos, L., Conde, I., Leitão, R. A., Ferreira, H. R. S., Gomes, C. M. F., Silva, A. P., Schmitt, F. C., Carvalho‐Maia, C., Lobo, J., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6319 · Cited by 8
Domrachev, B., Singh, S. S., Li, D., & Rudloff, U. (2021) · Journal of Cancer Treatment and Diagnosis · doi:10.29245/2578-2967/2021/1.1194 · Cited by 7
Novel exosome-related risk signature as prognostic biomarkers in glioblastoma
Ding, M., Xu, Q., Jin, X., Han, Z., Jiang, H., Sun, H., Jin, Y., Piao, Z., & Zhang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1071023 · Cited by 7
Self-citationThe tumour ecology of quiescence: Niches across scales of complexity
Castillo, S. P., Gálvez‐Cancino, F., Liu, J., Pollard, S. M., Quezada, S. A., & Yuan, Y. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.04.004 · Cited by 7
Activated KRAS reprograms neural progenitor cells to glioma stem cell‑like phenotype
Qin, Z., Liang, W., Zhang, Z., Li, P., Wang, T., Chen, Q., Guo, B., Zhong, Y., Kang, H., & Wang, L. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5536 · Cited by 7
The upregulation of VGF enhances the progression of oral squamous carcinoma
Chou, C., Yen, C.-H., Liu, C., Tu, H., Lin, S., & Chang, K. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03301-9 · Cited by 7
Kernel Differential Subgraph Analysis to Reveal the Key Period Affecting Glioblastoma
Xie, J., Sun, J., Feng, J., Yang, F., Wang, J., Wen, T., & Nie, Q. H. (2020) · Biomolecules · doi:10.3390/biom10020318 · Cited by 7
Zhang, M., Chen, H., Liang, B., Wang, X., Gu, N., Xue, F., Yue, Q., Zhang, Q., & Hong, J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.777921 · Cited by 7
Self-citationProteomic and functional comparison between human induced and embryonic stem cellsPreprint
Brenes, A. J., Griesser, E., Sinclair, L. V., Davidson, L., Prescott, A. R., Singh, F., Hogg, E. K. J., Espejo-Serrano, C., Jiang, H., Yoshikawa, H., et al. (2024) · eLife · doi:10.7554/elife.92025.3 · Cited by 7
Advancements in 3D gel culture systems for enhanced angiogenesis in bone tissue engineering
Shi, A., Shi, Y., Li, J., Ye, M., Ma, X., Peng, Y., Gai, K., & Chen, J. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb01139b · Cited by 6
Self-citationNuclear cholesterol regulates nuclear size and DNA damage responses in cancer stem cells
Duan, T., Taori, S., Bhargava, S., Lai, S., Zhong, C., Yomtoubian, S., Yuan, H., Wu, X., Zhang, P., Huang, T., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf110 · Cited by 6
Self-citationThinking in 3 dimensions: philosophies of the microenvironment in organoids and organs-on-chip
Caianiello, S., Bertolaso, M., & Militello, G. (2023) · History & Philosophy of the Life Sciences · doi:10.1007/s40656-023-00560-z · Cited by 6
Pang, F., He, W., Liu, X., Zou, Z., Wu, W., Wang, Y., Yang, P., Wen, B., Jiang, J., Teng, Y., et al. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154236 · Cited by 6
Oh, S.-I., Jeong, H., Park, H.-S., Choi, K., Hwang, I.-S., Lee, J., Cho, J., & Hong, S. (2020) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2020.1841783 · Cited by 6
Ruiz-Garcia, H., Zarco, N., Watanabe, F., Farias, V., Suárez-Meade, P., Guerrero‐Cazares, H., Imitola, J., Quiñones‐Hinojosa, A., & Trifiletti, D. M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2703-7_9 · Cited by 6
Innovative radiotherapies for the treatment of glioblastoma
Eupen, L. V., Waked, A., Primac, I., Vermeulen, K., Bie, I. D., Benotmane, M. A., & Quintens, R. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf255 · Cited by 5
Interdependencies of the Neuronal, Immune and Tumor Microenvironment in Gliomas
Yuile, A., Wei, J., Mohan, A. A., Hotchkiss, K. M., & Khasraw, M. (2023) · Cancers · doi:10.3390/cancers15102856 · Cited by 6
Zhou, H., Chen, B., Zhang, L., & Li, C. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.07.029 · Cited by 5
Zhang, H., Guan, S., Wang, L., Zhang, M., Wang, Z., & Dai, Z. H. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401817 · Cited by 5
Building Bonds: Cancer Stem Cells Depend on Their Progeny to Drive Tumor Progression
Muthukrishnan, S. D., Alvarado, A. G., & Kornblum, H. I. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.03.008 · Cited by 5
Kim, D. S. (2020) · Future Oncology · doi:10.2217/fon-2019-0606 · Cited by 5
Personalized Medicine in Brain Gliomas: Targeted Therapy, Patient-Derived Tumor Models (Review)
Сергеевич, Я. К., Yuzhakova, D. V., Sachkova, D. A., Kukhnina, L. S., Kharitonova, T. M., Zolotova, A. S., Medyanik, I. A., & Shirmanova, M. V. (2023) · Современные технологии в медицине · doi:10.17691/stm2023.15.3.07 · Cited by 4
Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choice
Savani, M. R., Li, B., Smith, B. C., Gu, W., Xiao, Y., Baquer, G., Shipman, T. E., Oken, S., Manoj, N., Zacharias, L. G., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01520-0 · Cited by 4
Spatial self-organization of cancer stem cell niches revealed by live single-cell imaging
Brulé, M., Horochowska, A., Fontaine, E., Ibad, R. T., Woesteland, F., Denoulet, M., Pesez, J., Adriaenssens, É., Toillon, R., Bourhis, X. L., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04681-z · Cited by 4
Li, Y., Kang, T., Jia, Z. H., Lu, C., Cui, G., Song, K., Yu, H., Dixit, D., Jin, F., Shan, D., et al. (2026) · Neuro-Oncology · doi:10.1093/neuonc/noag015 · Cited by 4
Self-citationNAT10-dependent N4-acetylcytidine reprograms R-loops and promotes cancer stem cell growth
Wu, X., Wang, D., Taori, S., Wu, W., Dixit, D., Lv, D., Mullett, S. J., Gelhaus, S. L., Yuan, F., Zhang, P., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117408 · Cited by 4
Self-citationHe, Z., Peng, Y., Wang, D., Yang, C., Zhou, C., Gong, B., Song, S., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1427200 · Cited by 4
Targeting the molecular mechanisms of glioma stem cell resistance to chemotherapy
Fares, J., Kanojia, D., Cordero, Á., Ulasov, I. V., & Lesniak, M. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821567-8.00014-2 · Cited by 4
Reprogramming the microenvironment: tricks of tumor-derived astrocytes
Zhang, G., & Rich, J. N. (2020) · Cell Research · doi:10.1038/s41422-020-0335-4 · Cited by 4
Self-citationHuman Glioblastoma Organoids to Model Brain Tumor Heterogeneity Ex Vivo
Pontius, W., Wallace, L. C., Fife, K., & Hubert, C. G. (2020) · Neuromethods · doi:10.1007/978-1-0716-0856-2_7 · Cited by 4
Self-citationBrain cancer stem cells: overview and potential targeted therapy
Güler, E. M., Koç, S., Dumlu, F. S., Beyaztaş, H., Özkan, B. N., & Bozalı, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-13212-4.00014-3 · Cited by 4
Cianci, F., Verduci, I., Cazzoli, R., Cannavale, G., Rey, G., Veronesi, M., Balboni, B., Ranucci, M., Palloni, L. M. G., Ballabio, F., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03577-3 · Cited by 3
Dominant clones leverage developmental epigenomic states to drive ependymoma
Kardian, A., Sun, H., Ippagunta, S. M., Laboe, N., Varadharajan, S., Yu, K., Chen, H., Emanus, E., Zheng, T., Deneen, R. M., et al. (2026) · Nature · doi:10.1038/s41586-026-10270-8 · Cited by 3
Self-citationDoualle, C., Gouju, J., Nouari, Y., Wery, M., Guittonneau, C., Codron, P., Rousseau, A., Saulnier, P., Eyer, J., & Letournel, F. (2023) · PubMed Central · Cited by 3
Inmunopatología del Glioblastoma Multiforme y su importancia en el ámbito clínico
Rodríguez, M. P. T., Garcia, K. A. M., Baquero, C. A. C., & Cruz, A. D. P. I. (2022) · Revista Ciencias Biomédicas · doi:10.32997/rcb-2022-3738 · Cited by 3
Changes in adrenoceptor expression level contribute to the cellular plasticity of glioblastoma cells
Asaka, Y., Masumoto, T., Uneda, A., Chin, V. D., Otani, Y., Peña, T., Katayama, H., Itano, T., Ando, T., Huang, R., et al. (2025) · The Journal of Physiological Sciences · doi:10.1016/j.jphyss.2025.100016 · Cited by 2
Hirano, S., Uneda, A., Otani, Y., Suruga, Y., Imoto, R., Hokama, M., Umeda, T., Ikemachi, R., Nishigaki, S., Tsuboi, N., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113456 · Cited by 2
Primary glioma cell culture: from monolayer to organoids
Pristyazhnyuk, I. E., Stupak, E. V., Stupak, V. V., & Menzorov, A. G. (2025) · PROTOPLASMA · doi:10.1007/s00709-025-02137-y · Cited by 2
Lee, Y. H. G., Tsoli, M., Shi, Y. C., Ip, C. K., & Ziegler, D. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10325-2 · Cited by 3
Self-citationJahouri, S., Montermini, L., Tawil, N., Jalali, M., Garzia, L., Jabado, N., & Rak, J. W. (2026) · Journal of Extracellular Biology · doi:10.1002/jex2.70152 · Cited by 2
Zhu, H., Cheng, L., Liu, D., Ma, Y., Fan, H., He, S., Liang, W., Mei, D., Ma, X., Li, R. H., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03930-z · Cited by 2
Communication of Glioma cells with neuronal plasticity: What is the underlying mechanism?
da Rosa, M. M. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104879 · Cited by 2
Manini, I., Dalla, E., Vendramin, V., Cesselli, D., Loreto, C. D., Škrap, M., & Ius, T. (2022) · Cancers · doi:10.3390/cancers14143413 · Cited by 2
Zhang, C., Lai, G., Deng, J., Li, K., Chen, L., Zhong, X., & Xie, B. (2024) · Molecular Biotechnology · doi:10.1007/s12033-023-01045-x · Cited by 2
Image‐based assessment of natural killer cell activity against glioblastoma stem cells
Du, Y., Metcalfe, S. C., Akunapuram, S., Ghosh, S., Spruck, C., Richardson, A. M., Cohen‐Gadol, A., & Shen, J. (2024) · FEBS Open Bio · doi:10.1002/2211-5463.13818 · Cited by 2
Metadata
- Authors
- Wang, X., Prager, B. C., Wu, Q., Kim, L. J. Y., Gimple, R. C., Shi, Y., Yang, K., Morton, A. R., Zhou, W., Zhu, Z., Obara, E. A. A., Miller, T. E., Song, A., Lai, S., Hubert, C. G., Jin, X., Huang, Z., Fang, X., Dixit, D., Tao, W., Zhai, K., Chen, C., Dong, Z., Zhang, G., Dombrowski, S. M., Hamerlik, P., Mack, S. C., Bao, S., & Rich, J. N.
- Affiliations
- University of California San Diego (US)
- Army Medical University (CN)
- Cleveland Clinic Lerner College of Medicine (US)
- Case Western Reserve University (US)
- Cleveland Clinic Research (US)
- Danish Cancer Society (DK)
- Baylor College of Medicine (US)
- Corresponding author
- Rich, Jeremy N.
- ORCID
- Wang, Xiuxing
- Prager, Briana C.
- Wu, Qiulian
- Kim, Leo J.Y.
- Gimple, Ryan C.
- Shi, Yu
- Yang, Kailin
- Morton, Andrew R.
- Zhou, Wenchao
- Zhu, Zhe
- Miller, Tyler E.
- Song, Anne
- Lai, Sisi
- Hubert, Christopher G.
- Jin, Xun
- Huang, Zhi
- Fang, Xiaoguang
- Dixit, Deobrat
- Tao, Weiwei
- Zhai, Kui
- Chen, Cong
- Dong, Zhen
- Zhang, Guoxin
- Dombrowski, Stephen M.
- Hamerlik, Petra
- Mack, Stephen C.
- Bao, Shideng
- Rich, Jeremy N.
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 22
- Issue
- 4
- Pages
- 514-528.e5
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- PMC
- PMC5947947
- OpenAlex
- W2796407886
- Cited by
- 285
- References
- 74
- Citations by year
- 2026: 20 · 2025: 28 · 2024: 54 · 2023: 42 · 2022: 25 · 2021: 40 · 2020: 31 · 2019: 30 · 2018: 14
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell stem cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (CA197718, CA154130, CA169117, CA171652, NS087913, NS089272, CA184090, NS091080, NS099175)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- glioblastoma, glioblastoma stem cells, tumor microenvironment, brain-derived neurotrophic factor, NTRK2, VGF, paracrine signaling, tumor progression, stemness, tumor growth, patient-derived tumor models, epigenetic profiles
- MeSH terms
- Brain Neoplasms, Cell Differentiation, Glioblastoma, Humans, Neoplastic Stem Cells, Signal Transduction, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review